On approximate equality of Z-values of the statistical tests for win statistics (win ratio, win odds, and net benefit).

Finkelstein-Schoenfeld test IPCW adjustment censoring bias inverse-probability-of-censoring weighting pairwise comparisons stratified win statistics

Journal

Journal of biopharmaceutical statistics
ISSN: 1520-5711
Titre abrégé: J Biopharm Stat
Pays: England
ID NLM: 9200436

Informations de publication

Date de publication:
08 Oct 2024
Historique:
medline: 8 10 2024
pubmed: 8 10 2024
entrez: 8 10 2024
Statut: aheadofprint

Résumé

Dong et al. (2023) showed that the win statistics (win ratio, win odds, and net benefit) can complement each another to demonstrate the strength of treatment effects in randomized trials with prioritized multiple outcomes. This result was built on the connections among the point and variance estimates of the three statistics, and the approximate equality of Z-values in their statistical tests. However, the impact of this approximation was not clear. This Discussion refines this approach and shows that the approximate equality of Z-values for the win statistics holds more generally. Thus, the three win statistics consistently yield closely similar p-values. In addition, our simulations show an example that the naive approach without adjustment for censoring bias may produce a completely opposite conclusion from the true results, whereas the IPCW (inverse-probability-of-censoring weighting) approach can effectively adjust the win statistics to the corresponding true values (i.e. IPCW-adjusted win statistics are unbiased estimators of treatment effect).

Identifiants

pubmed: 39377308
doi: 10.1080/10543406.2024.2374857
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-8

Auteurs

Gaohong Dong (G)

BeiGene, Ridgefield Park, New Jersey, USA.

Ying Cui (Y)

Department of Biomedical Data Science, Stanford University, Stanford, California, USA.

Margaret Gamalo-Siebers (M)

Pfizer Inc, Collegeville, Pennsylvania, USA.

Ran Liao (R)

Eli Lilly and Company, Indianapolis, Indiana, USA.

Dacheng Liu (D)

Boehringer Ingelheim, Ridgefield, Connecticut, USA.

David C Hoaglin (DC)

Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, Massachusetts, USA.

Ying Lu (Y)

Department of Biomedical Data Science, Stanford University, Stanford, California, USA.

Classifications MeSH